BioSig Technologies(BSGM)
icon
搜索文档
BioSig Technologies, Inc. (BSGM) CEO Ken Londoner on Phase II Human Trials for Broad-Spectrum Oral Anti-Viral for Treatment of COVID-19 (Transcript)
2020-06-10 05:05
Start Time: 11:00 January 1, 0000 11:47 AM ET BioSig Technologies, Inc. (OTCQB:BSGM) Special Call June 09, 2020, 11:00 AM ET Company Participants Ken Londoner - Chairman and CEO, BioSig Technologies Nick Spring - CEO, ViralClear Pharmaceuticals Steve King - COO, ViralClear pharmaceuticals Jerry Zeldis - Executive Chair, ViralClear Pharmaceuticals Andrew Ballou - VP, IR Conference Call Participants Yale Jen - Laidlaw & Company Scott Henry - ROTH Capital Gary Zwetchkenbaum - Plum Tree Consulting Todd Ammons - ...
BioSig Technologies, Inc. (BSGM) CEO Ken Londoner on Development Updates Regarding Vicromax Conference Call (Transcript)
2020-04-08 07:58
BioSig Technologies, Inc. (OTCQB:BSGM) Development Updates Regarding Vicromax Conference Call April 7, 2020 11:00 AM ET Company Participants Andy Ballou - VP, IR Ken Londoner - Chairman and CEO, BioSig Technologies Nick Spring - CEO, ViralClear Pharmaceuticals Steve King - COO, ViralClear pharmaceuticals Dr. Jerry Zeldis - Founder and Executive Chair, ViralClear Pharmaceuticals Dr. Andrew Badley - Physician Scientist, Mayo Clinic Conference Call Participants Gary Zwetchkenbaum - Plum Tree Consulting Hugh Ma ...